Advertisement
Screener

PROFOUND MEDICAL CORP. (PROF) Material Contracts

PROFOUND MEDICAL CORP. Material Contracts

Every material contract the company filed as Exhibit 10 (executive pay plans, credit agreements, supplier and indemnity agreements), newest first, with the filing's own description.

  • 2026-03-05: Form 10-K; Exhibit 10.5; Description Profound Medical Corp. Long Term Incentive Plan.
  • 2025-12-31: Form 8-K; Exhibit 10.1; Description Form of Subscription Agreement, dated December 30, 2025.
  • 2025-12-19: Form 8-K; Exhibit 10.1; Description Form of Securities Purchase Agreement, dated as of December 19, 2025, by and between Profound Medical Corp. and the purchaser parties thereto..
  • 2025-03-07: Form 10-K; Exhibit 10.9; Description Amended and Restated Credit Agreement, dated March 3, 2025, between the Company and Canadian Imperial Bank of Commerce.
FiledFormExhibitDescription
2026-03-0510-K10.5Profound Medical Corp. Long Term Incentive Plan
2025-12-318-K10.1Form of Subscription Agreement, dated December 30, 2025
2025-12-198-K10.1Form of Securities Purchase Agreement, dated as of December 19, 2025, by and between Profound Medical Corp. and the purchaser parties thereto.
2025-03-0710-K10.9Amended and Restated Credit Agreement, dated March 3, 2025, between the Company and Canadian Imperial Bank of Commerce
2025-03-0710-K10.8Siemens Agreement dated January 23, 2019. between the Company and Siemens Healthcare GmbH
2025-03-0710-K10.7Amended and Restated Technology License Agreement, dated May 16, 2011, by and between the Company and Sunnybrook Health Sciences Centre
2025-03-0710-K10.4Amended and Restated Employment Agreement, dated August 20, 2019, as amended, by and between the Company and Mathieu Burtnyk
2025-03-0710-K10.3Amended and Restated Employment Agreement, dated August 23, 2019, as amended, by and between the Company and Rashed Dewan
2025-03-0710-K10.2Employment Agreement, dated October 14, 2024, by and between the Company and Tom Tamberrino
2025-03-0710-K10.1Employment Agreement, dated January 1, 2020, as amended, by and between the Company and Arun Menawat

Similar stocks

Stock NameCountryMarket CapPE Ratio
Neuronetics, Inc. (STIM)United States$0.216B-3.25
PRO DEX INC (PDEX)United States$0.234B13.64
UTAH MEDICAL PRODUCTS INC (UTMD)United States$0.238B20.93
Lucid Diagnostics Inc. (LUCD)United States$0.170B
InfuSystem Holdings, Inc (INFU)United States$0.253B22.52
KORU Medical Systems, Inc. (KRMD)United States$0.151B-106.78
Anika Therapeutics, Inc. (ANIK)United States$0.272B-51.71
ORASURE TECHNOLOGIES INC (OSUR)United States$0.272B-6.26
Cytosorbents Corp (CTSO)United States$0.274B-1.29
TriSalus Life Sciences, Inc. (TLSI)United States$0.283B-9.92